FI955311L - Farmaseuttinen koostumuspohja - Google Patents

Farmaseuttinen koostumuspohja Download PDF

Info

Publication number: FI955311L
Authority: FI; Finland
Prior art keywords: pharmaceutical composition; composition base; base; pharmaceutical; composition
Prior art date: 1994-11-09

Application number

FI955311A

Other languages

English (en)

Swedish (sv)

Other versions

FI955311A0 (fi

FI955311A7 (fi

Inventor

Hans Georg Weder

Ute Isele

Original Assignee

Ciba Geigy Ag

Vesifact Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-09

Filing date

1995-11-06

Publication date

1996-05-10

1995-11-06 Application filed by Ciba Geigy Ag, Vesifact Ag filed Critical Ciba Geigy Ag

1995-11-06 Publication of FI955311A0 publication Critical patent/FI955311A0/fi

1996-05-10 Publication of FI955311L publication Critical patent/FI955311L/fi

1996-05-10 Publication of FI955311A7 publication Critical patent/FI955311A7/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Dispersion Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

FI955311A 1994-11-09 1995-11-06 Farmaseuttinen koostumuspohja FI955311A7 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH337594		1994-11-09
CH59595		1995-03-02

Publications (3)

Publication Number	Publication Date
FI955311A0 FI955311A0 (fi)	1995-11-06
FI955311L true FI955311L (fi)	1996-05-10
FI955311A7 FI955311A7 (fi)	1996-05-10

Family

ID=25685065

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FI955312A FI955312A7 (fi)	1994-11-09	1995-11-06	Staurosporiinijohdannaisen intravenoosit liuokset
FI955311A FI955311A7 (fi)	1994-11-09	1995-11-06	Farmaseuttinen koostumuspohja

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
FI955312A FI955312A7 (fi)	1994-11-09	1995-11-06	Staurosporiinijohdannaisen intravenoosit liuokset

Country Status (11)

Country	Link
US (1)	US5658898A (fi)
EP (2)	EP0711556A1 (fi)
JP (2)	JPH08208522A (fi)
KR (2)	KR960016890A (fi)
AU (2)	AU3661795A (fi)
CA (2)	CA2162341A1 (fi)
FI (2)	FI955312A7 (fi)
HU (2)	HUT78026A (fi)
IL (2)	IL115912A0 (fi)
NO (2)	NO954485L (fi)
NZ (2)	NZ280419A (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996037192A1 (en) *	1995-05-26	1996-11-28	Vesifact Ag	Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
EP0866689A1 (de) *	1995-12-12	1998-09-30	Vesifact Ag	Cortisolspray zur topischen verabreichung
DE19622224A1 (de)	1996-02-16	1997-08-21	Max Planck Gesellschaft	Phosphatidyloligoglycerine
DE69738416T2 (de) *	1996-06-18	2008-12-11	Kyowa Hakko Kogyo Co., Ltd.	Liposomale zubereitungen von indolocarbazol-derivaten
EP0979647A4 (en) *	1997-02-27	2006-07-19	Nippon Shinyaku Co Ltd	FAT EMULSION FOR ORAL ADMINISTRATION
ES2384094T3 (es)	1997-11-14	2012-06-29	Pacira Pharmaceuticals, Inc.	Producción de liposomas multivesiculares
TWI241915B (en)	1998-05-11	2005-10-21	Ciba Sc Holding Ag	A method of preparing a pharmaceutical end formulation using a nanodispersion
TW592713B (en) *	1998-05-11	2004-06-21	Ciba Sc Holding Ag	Use of nanodispersions in cosmetic end formulations
US7381423B2 (en)	1998-05-11	2008-06-03	Ciba Specialty Chemicals Corp.	Use of nanodispersions in cosmetic end formulations
US6200968B1 (en)	1998-08-06	2001-03-13	Cephalon, Inc.	Particle-forming compositions containing fused pyrrolocarbazoles
US7795246B2 (en) *	1998-08-06	2010-09-14	Cephalon, Inc.	Particle-forming compositions containing fused pyrrolocarbazoles
DE69929128T2 (de) *	1998-08-31	2006-06-29	Nipro Corp.	Nährstoffinfusionspräparat
GB9903547D0 (en)	1999-02-16	1999-04-07	Novartis Ag	Organic compounds
GB9924962D0 (en) *	1999-10-21	1999-12-22	Mrc Collaborative Centre	Allosteric sites on muscarinic receptors
EP1441737B1 (en)	2001-10-30	2006-08-09	Novartis AG	Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
KR100422763B1 (ko) *	2002-01-17	2004-03-12	주식회사 태평양	경피흡수 촉진 능력이 우수한 식물성 나노입자의 제조 및이를 함유하는 화장료 및 의약용 외용제 조성물
KR100490365B1 (ko) *	2002-04-25	2005-05-17	한불화장품주식회사	화장료용 나노 베지클을 함유하는 화장료 조성물
US20060115500A1 (en) *	2002-07-23	2006-06-01	Jithan Aukunuru	Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
KR101032281B1 (ko) *	2003-03-03	2011-05-06	플로리안 랑	진단 및 치료 표적으로서의 ｓｇｋ１
GB0305941D0 (en) *	2003-03-14	2003-04-23	Camurus Ab	Composition
EP1653973A1 (en)	2003-08-08	2006-05-10	Novartis AG	Combinations comprising staurosporines
MX2007001155A (es) *	2004-07-29	2007-08-14	Creabilis Therapeutics Spa	Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
JP5135852B2 (ja) *	2007-03-30	2013-02-06	日油株式会社	可溶化用組成物
KR100849537B1 (ko) *	2007-07-04	2008-07-31	유효경	코엔자임 큐텐의 나노에멀젼 조성물
WO2009067221A2 (en) *	2007-11-20	2009-05-28	Cephalon, Inc.	Microemulsion containing indolocarbazole compound and dosage forms containing the same
JP2012051823A (ja) *	2010-08-31	2012-03-15	Fujifilm Corp	難容性薬物含有水中油型乳化組成物及びその製造方法
KR101494594B1 (ko)	2011-08-30	2015-02-23	주식회사 종근당	약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
EP2787977A4 (en) *	2011-12-09	2015-05-06	Univ California	LIPOSOMAL ACTIVE INVERTING
KR101586791B1 (ko)	2012-12-28	2016-01-19	주식회사 종근당	ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US12151024B2 (en)	2021-01-22	2024-11-26	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en)	2021-01-22	2022-06-14	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en)	2021-01-22	2022-03-22	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en)	2021-01-22	2021-06-15	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
WO2023064464A1 (en)	2021-10-14	2023-04-20	Pacira Pharmaceuticals, Inc.	Bupivacaine multivesicular liposome formulations and uses thereof
US12251472B1 (en)	2024-05-20	2025-03-18	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en)	2024-05-20	2024-12-03	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en)	2024-05-20	2025-04-22	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6348214A (ja) *	1986-08-18	1988-02-29	Morishita Seiyaku Kk	１−〔２−（２，４−ジクロロフエニル）−３−メチル−１−ペンテニル〕−１ｈ−イミダゾ−ルを含有する水中油型脂肪乳剤
IL86632A0 (en) *	1987-06-15	1988-11-30	Ciba Geigy Ag	Derivatives substituted at methyl-amino nitrogen
US5093330A (en) *	1987-06-15	1992-03-03	Ciba-Geigy Corporation	Staurosporine derivatives substituted at methylamino nitrogen
CH677886A5 (fi) *	1989-06-26	1991-07-15	Hans Georg Prof Dr Weder
AU675930B2 (en) *	1992-02-18	1997-02-27	Pharmos Corp.	Dry compositions for preparing submicron emulsions
AU1911095A (en) *	1994-02-18	1995-09-04	Cephalon, Inc.	Aqueous indolocarbazole solutions

1995
- 1995-11-01 EP EP95810686A patent/EP0711556A1/de not_active Withdrawn
- 1995-11-01 EP EP95810687A patent/EP0711557A1/de not_active Withdrawn
- 1995-11-02 AU AU36617/95A patent/AU3661795A/en not_active Abandoned
- 1995-11-02 AU AU36616/95A patent/AU3661695A/en not_active Abandoned
- 1995-11-06 FI FI955312A patent/FI955312A7/fi unknown
- 1995-11-06 FI FI955311A patent/FI955311A7/fi unknown
- 1995-11-07 HU HU9503198A patent/HUT78026A/hu unknown
- 1995-11-07 NZ NZ280419A patent/NZ280419A/en unknown
- 1995-11-07 NZ NZ280420A patent/NZ280420A/en unknown
- 1995-11-07 US US08/553,126 patent/US5658898A/en not_active Expired - Fee Related
- 1995-11-07 CA CA002162341A patent/CA2162341A1/en not_active Abandoned
- 1995-11-07 CA CA002162342A patent/CA2162342A1/en not_active Abandoned
- 1995-11-07 HU HU9503199A patent/HUT74423A/hu unknown
- 1995-11-08 KR KR1019950040196A patent/KR960016890A/ko not_active Withdrawn
- 1995-11-08 NO NO954485A patent/NO954485L/no unknown
- 1995-11-08 JP JP7289511A patent/JPH08208522A/ja active Pending
- 1995-11-08 NO NO954486A patent/NO954486L/no unknown
- 1995-11-08 IL IL11591295A patent/IL115912A0/xx unknown
- 1995-11-08 JP JP7289508A patent/JPH08208486A/ja active Pending
- 1995-11-08 IL IL11591395A patent/IL115913A0/xx unknown
- 1995-11-08 KR KR1019950040197A patent/KR960016908A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
CA2162341A1 (en)	1996-05-10
CA2162342A1 (en)	1996-05-10
IL115912A0 (en)	1996-01-31
AU3661795A (en)	1996-05-23
FI955312A0 (fi)	1995-11-06
EP0711556A1 (de)	1996-05-15
US5658898A (en)	1997-08-19
FI955311A0 (fi)	1995-11-06
NZ280420A (en)	1997-03-24
HUT74423A (en)	1996-12-30
JPH08208522A (ja)	1996-08-13
AU3661695A (en)	1996-05-23
NO954485D0 (no)	1995-11-08
IL115913A0 (en)	1996-01-31
EP0711557A1 (de)	1996-05-15
NO954485L (no)	1996-05-10
FI955312L (fi)	1996-05-10
KR960016908A (ko)	1996-06-17
NO954486L (no)	1996-05-10
JPH08208486A (ja)	1996-08-13
FI955312A7 (fi)	1996-05-10
NZ280419A (en)	1997-04-24
FI955311A7 (fi)	1996-05-10
KR960016890A (ko)	1996-06-17
HUT78026A (hu)	1999-05-28
HU9503199D0 (en)	1996-01-29
HU9503198D0 (en)	1996-01-29
NO954486D0 (no)	1995-11-08

Publication	Publication Date	Title
FI955311L (fi)	1996-05-10	Farmaseuttinen koostumuspohja
FI20071025L (fi)	2007-12-28	Farmaseuttisia koostumuksia
NO20004345L (no)	1996-12-23	Farmasøytisk sammensetning
FI944832L (fi)	1995-04-16	Farmaseuttinen koostumus
ID18352A (id)	1998-04-02	Komposisi-komposisi farmasi
ITMI932540A0 (it)	1993-12-03	Composizione farmaceutica
BR9507768A (pt)	1997-09-02	Composição farmacêutica
ID29294A (id)	2001-08-16	Komposisi farmasi
FI973229A0 (fi)	1997-08-05	Uusi farmaseuttinen koostumus
LV11727A (lv)	1997-04-20	Farmaceitiska kompozicija
ID18698A (id)	1998-04-30	Komposisi farmasi
ITMI942166A0 (it)	1994-10-21	Composizioni farmaceutiche miorilassanti
ID25857A (id)	2000-11-09	Komposisi farmasi
FI973280L (fi)	1997-08-08	Farmaseuttinen koostumus
FI961364L (fi)	1997-09-26	Lääkeainekoostumus
ITMI962628A0 (it)	1996-12-16	Composizione farmaceutica
BR9605777A (pt)	1998-08-25	Composição farmacêutica
FI954050L (fi)	1996-03-02	Lääkekoostumuksia
FI962738A7 (fi)	1996-07-03	Farmaseuttiset koostumukset
ID23531A (id)	2000-04-27	Komposisi farmasi
NO964309D0 (no)	1996-10-10	Farmasöytisk sammensetning
IT1272935B (it)	1997-07-01	Composizione farmaceutica contenente n-acetil-cisteina
SE9402924D0 (sv)	1994-09-02	Novel pharmaceutical composition
SE9402437D0 (sv)	1994-07-11	Pharmaceutical composition
KR960016881A (ko)	1996-06-17	제약 조성물

Legal Events

Date	Code	Title	Description
1997-08-27	GB	Transfer or assigment of application	Owner name: NOVARTIS AG